BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20609300)

  • 21. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
    J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F; Lehmann S; Maridonneau-Parini I
    Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Unfolding chaperone as a prion protein relating molecule].
    Hachiya NS; Sakasegawa Y; Kaneko K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain.
    Bailly Y; Haeberlé AM; Blanquet-Grossard F; Chasserot-Golaz S; Grant N; Schulze T; Bombarde G; Grassi J; Cesbron JY; Lemaire-Vieille C
    J Comp Neurol; 2004 May; 473(2):244-69. PubMed ID: 15101092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of the cellular prion protein in the central nervous system of the chicken.
    Atoji Y; Ishiguro N
    J Chem Neuroanat; 2009 Dec; 38(4):292-301. PubMed ID: 19751818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma.
    Williams WM; Stadtman ER; Moskovitz J
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):161-8. PubMed ID: 15043713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmissible spongiform encephalopathies.
    Liemann S; Glockshuber R
    Biochem Biophys Res Commun; 1998 Sep; 250(2):187-93. PubMed ID: 9753605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion diseases of the central nervous system.
    Prusiner SB; DeArmond SJ
    Monogr Pathol; 1990; (32):86-122. PubMed ID: 2192281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prion biology: update].
    Weber EL
    Rev Argent Microbiol; 1999; 31(4):205-18. PubMed ID: 10615684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prion infection of differentiated neurospheres.
    Herva ME; Relaño-Ginés A; Villa A; Torres JM
    J Neurosci Methods; 2010 May; 188(2):270-5. PubMed ID: 20206206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.
    Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human prion diseases: molecular and clinical aspects.
    Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
    Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of PrP(C) in the rat brain and characterization of a subset of cortical neurons.
    Moleres FJ; Velayos JL
    Brain Res; 2005 Sep; 1056(1):10-21. PubMed ID: 16109385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy.
    Veith NM; Plattner H; Stuermer CA; Schulz-Schaeffer WJ; Bürkle A
    Eur J Cell Biol; 2009 Jan; 88(1):45-63. PubMed ID: 18834644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do bovine lymphocytes express a peculiar prion protein?
    Mélot F; Thielen C; Labiet T; Eisher S; Jolois O; Heinen E; Antoine N
    Dev Immunol; 2002 Dec; 9(4):245-52. PubMed ID: 15144021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases.
    Voigtländer T; Klöppel S; Birner P; Jarius C; Flicker H; Verghese-Nikolakaki S; Sklaviadis T; Guentchev M; Budka H
    Acta Neuropathol; 2001 May; 101(5):417-23. PubMed ID: 11484812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular prion protein is expressed in a subset of neuroendocrine cells of the rat gastrointestinal tract.
    Marcos Z; Pffeifer K; Bodegas ME; Sesma MP; Guembe L
    J Histochem Cytochem; 2004 Oct; 52(10):1357-65. PubMed ID: 15385582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular prion protein protects against reactive-oxygen-species-induced DNA damage.
    Watt NT; Routledge MN; Wild CP; Hooper NM
    Free Radic Biol Med; 2007 Sep; 43(6):959-67. PubMed ID: 17697940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.